References
1. Dedov I.I., Shestakova M.V., Vikulova O.K. Epidemiology of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the federal diabetes register. Sakharniy diabet [Diabetes Mellitus]. 2017; 20 (1): 13–41. DOI: https://doi.org/10.14341/DM8664 (in Russian)
2. International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium, 2021. URL: https://www.diabetesatlas.org
3. Franks P.W., Pearson E., Florez J.C. Gene-environment and gene-treatment interactions in type 2 diabetes: progress, pitfalls, and prospects. Diabetes Care. 2013; 36 (5): 1413–21. DOI: https://doi.org/10.2337/dc12-2211
4. Savic D., Ye H., Aneas I., Park S.Y., Bell G.I., Nobrega M.A. Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res. 2011; 21 (9): 1417–25. DOI: https://doi.org/10.1101/gr.123745.111
5. Boj S.F., van Es J.H., Huch M., Li V.S., Jose´ A., Hatzis P., et al. Diabetes risk gene and Wnt effector TCF7L2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 2012; 151 (7): 1595–607. DOI: https://doi.org/10.1016/j.cell.2012.10.053
6. Gupta V., Khadgawat R., Saraswathy K.N., Sachdeva M.P., Kalla A.K. Emergence of TCF7L2 as a most promising gene in predisposition of diabetes type II. Int J Hum Genet. 2008; 8 (1–2): 199–215. DOI: https://doi.org/10.1080/09723757.2008.11886031
7. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006; 38: 320–3. DOI: https://doi.org/10.1038/ng1732
8. Scott L.J., Bonnycastle L.L., Willer C.J., Sprau A.G., Jackson A.U., Narisu N. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes. 2006; 55: 2649–53. DOI: https://doi.org/10.2337/db06-0341
9. Zhang C., Qi L., Hunter D.J., Meigs Z.B., Manson J.A.E., van Dam R.M., et al. Variant of transcription factor 7-like 2 (TCFL2) gene and the risk of type 2 diabetes in large cohorts of US women and men. Diabetes. 2006; 55: 2645–8. DOI: https://doi.org/10.2337/db06-0643
10. Lyssenko V., Lupi R., Marchetti P., Lyssenko V., Lupi R., Marchetti P., et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest. 2007; 117 (8): 2155–63. DOI: https://doi.org/10.1172/JCI30706
11. Ip W., Shao W., Chiang Y.T., Jin T. The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis. Am J Physiol Endocrinol Metab. 2012; 303 (9): E1166–76. DOI: https://doi.org/10.1152/ajpendo.00249.2012
12. Jin T. Current understanding and dispute on the function of the Wnt signaling pathway effector TCF7L2 in hepatic gluconeogenesis. Genes Dis. 2015; 3 (1): 48–55. DOI: https://doi.org/10.1016/j.gendis.2015. 10.002
13. Dedov I.I., Shestakov M.V., Mayorov A.Yu., eds. Algorithms of specialized medical care for patients with diabetes mellitus. 10th ed. Moscow, 2021. DOI: https://doi.org/10.14341/DM12802 (in Russian)
14. Delsoglio M., Achamrah N., Berger M.M., Pichard C. Indirect calorimetry in clinical practice. J Clin Med. 2019; 8 (9): 1387. DOI: https://doi.org/10.3390/jcm8091387
15. Dujic T., Bego T., Malenica M., Velija-Asimi Z., Ahlqvist E., Groop L. Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes. Bosn J Basic Med Sci. 2019; 19 (4): 368–74. DOI: https://doi.org/10.17305/bjbms.2019.4181
16. Pearson E.R., Donnelly L.A., Kimber C., Whitley A., Doney A.S., McCarthy M.I., et al. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes. 2007; 56 (8): 2178–82. DOI: https://doi.org/10.2337/db07-0440
17. Srinivasan S., Kaur V., Chamarthi B., Littleton K.R., Chen L., Manning A.K., et al. TCF7L2 genetic variation augments incretin resistance and influences response to a sulfonylurea and metformin: the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH). Diabetes Care. 2018; 41 (3): 554–61. DOI: https://doi.org/10.2337/dc17-1386
18. Mattei J., Qi Q., Hu F.B., Sacks F.M., Qi L. TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention. Am J Clin Nutr. 2012; 96 (5): 1129–36. DOI: https://doi.org/10.3945/ajcn.112.038125